Piyatip Khuntayaporn1, Pohnvipa Kanathum1, Jantana Houngsaitong2, Preecha Montakantikul2, Krit Thirapanmethee1, Mullika Traidej Chomnawang3. 1. Department of Microbiology, Faculty of Pharmacy, Mahidol University, 447 Sri Ayudthya Rd, Rajathevi, Bangkok, 10400, Thailand. 2. Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri Ayudthya Rd, Rajathevi, Bangkok, 10400, Thailand. 3. Department of Microbiology, Faculty of Pharmacy, Mahidol University, 447 Sri Ayudthya Rd, Rajathevi, Bangkok, 10400, Thailand. mullika.tra@mahidol.ac.th.
Abstract
BACKGROUND: Acinetobacter baumannii has emerged as one of the common multidrug resistance pathogens causing hospital-acquired infections. This study was conducted to elucidate the distribution of antimicrobial resistance genes in the bacterial population in Thailand. Multidrug-resistant A. baumannii (MDR A. baumannii) isolates were characterized phenotypically, and the molecular epidemiology of clinical isolates in 11 tertiary hospitals was investigated at a country-wide level. METHODS: A total of 135 nonrepetitive MDR A. baumannii isolates collected from tertiary care hospitals across 5 regions of Thailand were examined for antibiotic susceptibility, resistance genes, and sequence types. Multilocus sequence typing (MLST) was performed to characterize the spread of regional lineages. RESULTS: ST2 belonging to IC2 was the most dominant sequence type in Thailand (65.19%), and to a lesser extent, there was also evidence of the spread of ST164 (10.37%), ST129 (3.70%), ST16 (2.96%), ST98 (2.96%), ST25 (2.96%), ST215 (2.22%), ST338 (1.48%), and ST745 (1.48%). The novel sequence types ST1551, ST1552, ST1553, and ST1557 were also identified in this study. Among these, the blaoxa-23 gene was by far the most widespread in MDR A. baumannii, while the blaoxa-24/40 and blaoxa-58 genes appeared to be less dominant in this region. The results demonstrated that the predominant class D carbapenemase was blaOXA-23, followed by the class B carbapenemase blaNDM-like, while the mcr-1 gene was not observed in any isolate. Most of the MDR A. baumannii isolates were resistant to ceftazidime (99.23%), gentamicin (91.85%), amikacin (82.96%), and ciprofloxacin (97.78%), while all of them were resistant to carbapenems. The results suggested that colistin could still be effective against MDR A. baumannii in this region. CONCLUSION: This is the first molecular epidemiological analysis of MDR A. baumannii clinical isolates at the national level in Thailand to date. Studies on the clonal relatedness of MDR A. baumannii isolates could generate useful data to understand the local epidemiology and international comparisons of nosocomial outbreaks.
BACKGROUND:Acinetobacter baumannii has emerged as one of the common multidrug resistance pathogens causing hospital-acquired infections. This study was conducted to elucidate the distribution of antimicrobial resistance genes in the bacterial population in Thailand. Multidrug-resistant A. baumannii (MDR A. baumannii) isolates were characterized phenotypically, and the molecular epidemiology of clinical isolates in 11 tertiary hospitals was investigated at a country-wide level. METHODS: A total of 135 nonrepetitive MDR A. baumannii isolates collected from tertiary care hospitals across 5 regions of Thailand were examined for antibiotic susceptibility, resistance genes, and sequence types. Multilocus sequence typing (MLST) was performed to characterize the spread of regional lineages. RESULTS:ST2 belonging to IC2 was the most dominant sequence type in Thailand (65.19%), and to a lesser extent, there was also evidence of the spread of ST164 (10.37%), ST129 (3.70%), ST16 (2.96%), ST98 (2.96%), ST25 (2.96%), ST215 (2.22%), ST338 (1.48%), and ST745 (1.48%). The novel sequence types ST1551, ST1552, ST1553, and ST1557 were also identified in this study. Among these, the blaoxa-23 gene was by far the most widespread in MDR A. baumannii, while the blaoxa-24/40 and blaoxa-58 genes appeared to be less dominant in this region. The results demonstrated that the predominant class D carbapenemase was blaOXA-23, followed by the class B carbapenemase blaNDM-like, while the mcr-1 gene was not observed in any isolate. Most of the MDR A. baumannii isolates were resistant to ceftazidime (99.23%), gentamicin (91.85%), amikacin (82.96%), and ciprofloxacin (97.78%), while all of them were resistant to carbapenems. The results suggested that colistin could still be effective against MDR A. baumannii in this region. CONCLUSION: This is the first molecular epidemiological analysis of MDR A. baumannii clinical isolates at the national level in Thailand to date. Studies on the clonal relatedness of MDR A. baumannii isolates could generate useful data to understand the local epidemiology and international comparisons of nosocomial outbreaks.
Entities:
Keywords:
A. baumannii; Antimicrobial resistance; Carbapenemases; MDR; MLST; Molecular epidemiology; Sequence type
Authors: Jane F Turton; Neil Woodford; Judith Glover; Susannah Yarde; Mary E Kaufmann; Tyrone L Pitt Journal: J Clin Microbiol Date: 2006-08 Impact factor: 5.948
Authors: Sergio G Bartual; Harald Seifert; Corinna Hippler; M Angeles Domínguez Luzon; Hilmar Wisplinghoff; Francisco Rodríguez-Valera Journal: J Clin Microbiol Date: 2005-09 Impact factor: 5.948
Authors: Mansura S Mulani; Ekta E Kamble; Shital N Kumkar; Madhumita S Tawre; Karishma R Pardesi Journal: Front Microbiol Date: 2019-04-01 Impact factor: 5.640
Authors: Rosesathorn Soontarach; Potjanee Srimanote; Mark C Enright; George Blundell-Hunter; Matthew J Dorman; Nicholas R Thomson; Peter W Taylor; Supayang P Voravuthikunchai Journal: Pharmaceuticals (Basel) Date: 2022-04-02
Authors: Samira M Hamed; Amira F A Hussein; Mohamed H Al-Agamy; Hesham H Radwan; Mai M Zafer Journal: Front Microbiol Date: 2022-07-22 Impact factor: 6.064
Authors: Adam Valcek; Kristina Nesporova; Clémence Whiteway; Tim De Pooter; Wouter De Coster; Mojca Strazisar; Charles Van der Henst Journal: Antimicrob Agents Chemother Date: 2022-08-15 Impact factor: 5.938
Authors: Erkison Ewomazino Odih; Emmanuel Oladayo Irek; Temitope O Obadare; Anderson O Oaikhena; Ayorinde O Afolayan; Anthony Underwood; Anthony T Adenekan; Veronica O Ogunleye; Silvia Argimon; Anders Dalsgaard; David M Aanensen; Iruka N Okeke; A Oladipo Aboderin Journal: Front Med (Lausanne) Date: 2022-03-07